Zobrazeno 1 - 10 of 58 pro vyhledávání: '"Hong‐Mei Yi"'
1
Akademický článek
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
Autor: Jie Xiong, Shu Cheng, Xiao Gao, Shan-He Yu, Yu-Ting Dai, Xin-Yun Huang, Hui-Juan Zhong, Chao-Fu Wang, Hong-Mei Yi, Hao Zhang, Wei-Guo Cao, Rong Li, Wei Tang, Yan Zhao, Peng-Peng Xu, Li Wang, Wei-Li Zhao
Publikováno v: Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract Natural killer T cell lymphoma (NKTCL) is highly aggressive, with advanced stage patients poorly responding to intensive chemotherapy. To explore effective and safe treatment for newly diagnosed advanced stage NKTCL, we conducted a phase II
Externí odkaz: https://doaj.org/article/86ceca8eb03c4db8b1b374d52b9cbacd
Zobrazit plný text záznamu
3
Akademický článek
Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial
Autor: Qing Shi, Yang He, Hong‐Mei Yi, Rong‐Ji Mu, Xu‐Feng Jiang, Di Fu, Lei Dong, Wei Qin, Peng‐Peng Xu, Shu Cheng, Qi Song, Sai‐Juan Chen, Li Wang, Wei‐Li Zhao
Publikováno v: Cancer Communications, Vol 43, Iss 8, Pp 896-908 (2023)
Abstract Background The current standard of care for non‐bulky diffuse large B‐cell lymphoma (DLBCL) patients with an International Prognostic Index (IPI) of 0 is four cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine and predni
Externí odkaz: https://doaj.org/article/1163de2be82f48f9be90c60c27e4f702
Zobrazit plný text záznamu
6
Akademický článek
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
Autor: Meng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, Yang He, Xiao Li, Di Fu, Yu-Ting Dai, Hai Fang, Shu Cheng, Peng-Peng Xu, Ying Qian, Yan Feng, Qian Liu, Li Wang, Wei-Li Zhao
Publikováno v: Frontiers in Oncology, Vol 12 (2022)
Lymphoma cells expressing CD5 (CD5+) confer inferior outcome of diffuse large B-cell lymphoma (DLBCL), especially in non–MYC/BCL2 double expressor (non-DE) patients. In tumor microenvironment, CD5+ non-DE tumor revealed increased proportion of immu
Externí odkaz: https://doaj.org/article/b4cd613d9ee74cb5ab5abf956128b898
Zobrazit plný text záznamu
8
Akademický článek
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Autor: Ping Zhao, Meng-Meng Ji, Ying Fang, Xiao Li, Hong-Mei Yi, Zi-Xun Yan, Shu Cheng, Peng-Peng Xu, Anne Janin, Chao-Fu Wang, Li Wang, Wei-Li Zhao
Publikováno v: Cell Death and Disease, Vol 12, Iss 4, Pp 1-14 (2021)
Abstract Long noncoding RNAs (lncRNAs) play an essential role in tumor progression. Few researches focused on the clinical and biological relevance of lncRNAs in peripheral T cell lymphoma (PTCL). In this research, a novel lncRNA (ENST00000503502) wa
Externí odkaz: https://doaj.org/article/eee260edbd6942dcb214ca0f9fa4119e
Zobrazit plný text záznamu
9
Akademický článek
Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells.
Autor: Xin-Hui Li, Jia-Quan Qu, Hong Yi, Peng-Fei Zhang, Hong-Mei Yi, Xun-Xun Wan, Qiu-Yan He, Xu Ye, Li Yuan, Jing-Feng Zhu, Jiao-Yang Li, Zhi-Qiang Xiao
Publikováno v: PLoS ONE, Vol 9, Iss 1, p e87767 (2014)
BACKGROUND:The purpose of this study was to identify miRNAs and genes involved in nasopharyngeal carcinoma (NPC) radioresistance, and explore the underlying mechanisms in the development of radioresistance. METHODS:We used microarrays to compare the
Externí odkaz: https://doaj.org/article/63c9aa244b0640f980f705812784ba24
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje